What's New in Anticoagulation

Tex Heart Inst J. 2016 Oct 1;43(5):419-421. doi: 10.14503/THIJ-16-5920. eCollection 2016 Oct.
No abstract available

Keywords: Anticoagulants/administration & dosage/therapeutic use; United States/epidemiology; atrial fibrillation/drug therapy; factor Xa inhibitors; heart diseases/therapy; metabolic clearance rate; practice guidelines as topic; risk factors; vitamin K/antagonists & inhibitors.

MeSH terms

  • Administration, Oral
  • Anticoagulants / administration & dosage*
  • Anticoagulants / adverse effects
  • Atrial Fibrillation / blood
  • Atrial Fibrillation / diagnosis
  • Atrial Fibrillation / drug therapy*
  • Atrial Fibrillation / epidemiology
  • Blood Coagulation / drug effects*
  • Hemorrhage / chemically induced
  • Humans
  • Patient Selection
  • Risk Factors
  • Stroke / blood
  • Stroke / diagnosis
  • Stroke / epidemiology
  • Stroke / prevention & control*
  • Treatment Outcome

Substances

  • Anticoagulants